Literature DB >> 27278937

Postmenopausal hyperandrogenism: the under-recognized value of inhibins.

Jasmin L Shearer1, Nabeel Salmons2, Damian J Murphy3, Rousseau Gama1,4.   

Abstract

We report a 70-year-old female presenting with increased libido and mild but rapid onset virilism. Investigations showed markedly elevated androstenedione and 17 hydroxyprogesterone misdirecting to possible late-onset congenital adrenal hyperplasia. High serum testosterone and oestrogens with suppressed gonadotrophins, however, indicated an androgen-secreting tumour. A normal dehydroepiandrosterone sulphate and elevated inhibins A and B indicated the tumour was ovarian in origin, which was confirmed on pelvic examination and imaging. At laparotomy, a right ovarian sertoliform endometrioid carcinoma was removed, following which the patient developed menopausal vasomotor symptoms and improvement of her virilism. Serum testosterone, oestradiol, inhibins A and B became undetectable, gonadotrophins appropriately increased and 17 hydroxyprogesterone and androstenedione normalized. We propose that inhibins may be of diagnostic value and should be included in investigative algorithms of females with virilization and hyperandrogenaemia, especially if postmenopausal. Androgen-secreting tumours must be excluded before raised 17 hydroxyprogesterone concentrations are used to diagnose late-onset congenital adrenal hyperplasia in females with new-onset virilization.

Entities:  

Keywords:  Cancer; steroid hormones; tumour markers

Mesh:

Substances:

Year:  2016        PMID: 27278937     DOI: 10.1177/0004563216656873

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  2 in total

1.  Inhibin A as a tumor marker for primary bilateral macronodular adrenal hyperplasia.

Authors:  Rachel Wurth; Crystal Kamilaris; Naris Nilubol; Samira M Sadowski; Annabel Berthon; Martha M Quezado; Fabio R Faucz; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-04-29

2.  Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism.

Authors:  Krishnakumar Rajamani; Richard G Moore; Sheena M Stanard; Olga Astapova
Journal:  AACE Clin Case Rep       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.